Tilray Brands (TLRY) Depreciation and Depletion (2017 - 2019)
Tilray Brands (TLRY) posted Depreciation and Depletion of $8.5 million for Q4 2019, up 4235.53% on a QoQ basis from $197000.0 in Q3 2019, and up 190.21% year-over-year from $2.9 million in Q4 2018.
Tilray Brands (TLRY) Depreciation and Depletion (2017 - 2019) Analysis & Trends
Tilray Brands' Depreciation and Depletion history runs 3 years deep, the most recent figure standing at $8.5 million for Q4 2019.
- Quarterly Depreciation and Depletion rose 190.21% year-over-year to $8.5 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $12.7 million (up 244.57% YoY) and the FY2020 annual result came in at $12.5 million, up 34.76% from the prior year.
- Depreciation and Depletion was $8.5 million for Q4 2019 at Tilray Brands, up from $197000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $8.5 million in Q4 2019 and bottomed at $157000.0 in Q2 2018.
- A 3-year average of $1.5 million and a median of $368000.0 in 2017 frame the typical range for Depreciation and Depletion.
- Peak annual rise in Depreciation and Depletion reached 602.39% in 2018, while the deepest fall reached 53.55% in 2018.
- Tilray Brands' Depreciation and Depletion stood at $419000.0 in 2017, then soared by 602.39% to $2.9 million in 2018, then surged by 190.21% to $8.5 million in 2019.
- Business Quant data shows TLRY's Depreciation and Depletion at $8.5 million in Q4 2019, $197000.0 in Q3 2019, and $999000.0 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 8.54 Mn |
| Dec 31, 2019 | 8.54 Mn |
| Sep 30, 2019 | 197,000.00 |
| Sep 30, 2019 | 197,000.00 |
| Mar 31, 2019 | 999,000.00 |
| Mar 31, 2019 | 999,000.00 |
| Dec 31, 2018 | 2.94 Mn |
| Dec 31, 2018 | 2.94 Mn |
| Sep 30, 2018 | 208,000.00 |
| Sep 30, 2018 | 208,000.00 |
| Jun 30, 2018 | 157,000.00 |
| Jun 30, 2018 | 157,000.00 |
| Mar 31, 2018 | 372,000.00 |
| Mar 31, 2018 | 372,000.00 |
| Dec 31, 2017 | 419,000.00 |
| Dec 31, 2017 | 419,000.00 |
| Sep 30, 2017 | 364,000.00 |
| Sep 30, 2017 | 364,000.00 |
| Jun 30, 2017 | 338,000.00 |
| Jun 30, 2017 | 338,000.00 |